Table 3.
Linear regression analysis for the correlation of flowmediated dilation (FMD) and risk factors
FMD | Group normal | Group metabolic syndrome | ||
---|---|---|---|---|
r | p | r | p | |
Weight(kg) | -0.293 | 0.056 | -0.491 | 0.001 |
BMI(kg/m) | 0.207 | 0.152 | 0.247 | 0.061 |
Waist circumference (cm) | -0.293 | 0.056 | -0.491 | 0.001 |
WHR | -0.039 | 0.833 | -0.444 | 0.001 |
SBP (mm Hg) | 0.211 | 0.147 | 0.290 | 0.016 |
DBP (mm Hg) | 0.252 | 0.099 | 0.275 | 0.023 |
FBG (mmol/L) | -0.218 | 0.140 | -0.223 | 0.078 |
Triglycerides, mmol/l | -0.128 | 0.407 | -0.152 | 0.243 |
Total cholesterol, mmol/l | -0.050 | 0.732 | -0.003 | 0.983 |
HDL-C, mmol/l | -0.116 | 0.523 | 0.266 | 0.050 |
LDL-C, mmol/l | -0.192 | 0.194 | -0.046 | 0.711 |
CRP, mg/l | -0.030 | 0.837 | -0.001 | 0.933 |
Resistin (ng/ml) | 0.034 | 0.818 | 0.203 | 0.115 |
ET-1(pg/ml) | -0.132 | 0.375 | -0.075 | 0.050 |
FMD: Flow-mediated dilation; BMI: Body mass index; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; FBG: Fasting blood glucose; HDL: high density lipoprotein; LDL: Low density lipoprotein; CRP: C-reactive protein; ET-1: Endothelin-1